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Background:  Surgical series on mitral valve reoperation are limitedby small numbers and inclusion of younger patients. With emerging 
percutaneousmitral technologies, knowing the observed mortality rate in contemporarypractice for elderly patients undergoing mitral 
reoperation can be used toguide patient selection.
methods:  This is a descriptive analysis of 1,068 Medicarebeneficiaries ≥ 65 years of age who underwent mitral reoperation over a 7 
yearfollow up period after an initial mitral operation (repair or replacement) thattook place between 2000 and 2002. The primary outcomes 
were hospital mortalityand long-term survival.
results:  The initial operation was repair in 44.1%, bioprosthetic replacementin 21.3%, and mechanical replacement in 34.6%. At 
reoperation, median age was72 years and comorbidities were common, including heart failure in 72.8%,stroke in 14%, COPD in 24.7%, 
renal failure in 14.6%, and atrialfibrillation/flutter in 50.5%. Non-elective reoperation was performed in 65.7%and 8.2% had endocarditis. 
At reoperation, only 10.8% of repair patientsunderwent re-repair. Concomitant procedures included tricuspidrepair/replacement in 7.5%, 
AVR in 10.3% and CABG in 11.8%. IABP was requiredin 9.7%. Median LOS was 12 days (IQR 8-21). Hospital mortality was 13.5% andwas 
similar for repair (12.7%), bioprosthetic replacement (12.9%) or mechanicalreplacement (14.3%) (p=0.7869). Reoperative mortality was 
similar for males vs females (11.9% vs 14.9%,p=0.1534) and for patients ≤ 75 vs >75 years of age (12.7% vs 15.6%, p=0.2021), and was 
significantly higher for non-elective vs elective operation (16.9% vs. 6.9%, p=0.0001) and for patients with vs without endocarditis (23.9% 
vs. 12.6%,p=0.0029). Cumulative long-term survival rates were 78.1% at 6 months, 75.4% at1 year, 66.1% at 3 years and 55.4% at 5 
years.
conclusion:  Mitral reoperation in the elderly carries high surgicalrisk. This cohort may be highly selected, further underestimating these 
results. Several factors including the presence of mechanical prosthesis, need forurgent intervention or concomitant procedures, and the 
presence ofendocarditis, may limit application of percutaneous treatment modalities.
